Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Liu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
ACS Applied Materials & Interfaces|November 25, 2010
Dioxythiophene-based polymer electrodes for supercapacitor modulesDavid Y Liu, John R Reynolds
Case Reports in Medicine|May 7, 2020
A Case of Acute Motor Sensory Axonal Neuropathy: A Variant of Guillain-Barré Syndrome, with Possible Syndrome of Irreversible Lithium-Effectuated NeurotoxicityDavid Y Liu, Jessica R Hollenbach, Jason A Gregorin, et al.
Hypoxia (Auckland, N.Z.)|March 24, 2017
Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancerTodd W Seeley, Mark D Sternlicht, Stephen J Klaus, et al.
Skeletal Muscle|May 31, 2016
The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regenerationRegan-Heng Zhang, Robert N Judson, David Y Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 31, 2010
Broadly absorbing black to transmissive switching electrochromic polymersPengjie Shi, Chad M Amb, Eric P Knott, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogueBabu J Mavunkel, Sarvajit Chakravarty, John J Perumattam, et al.
Gastroenterology|September 2, 2021
PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative ColitisWilliam J Sandborn, Larry C Mattheakis, Nishit B Modi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2020
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney DiseaseUghetta Del Balzo, Pierre E Signore, Gail Walkinshaw, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
ACS Applied Materials & Interfaces|November 25, 2010
Dioxythiophene-based polymer electrodes for supercapacitor modulesDavid Y Liu, John R Reynolds
Case Reports in Medicine|May 7, 2020
A Case of Acute Motor Sensory Axonal Neuropathy: A Variant of Guillain-Barré Syndrome, with Possible Syndrome of Irreversible Lithium-Effectuated NeurotoxicityDavid Y Liu, Jessica R Hollenbach, Jason A Gregorin, et al.
Hypoxia (Auckland, N.Z.)|March 24, 2017
Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancerTodd W Seeley, Mark D Sternlicht, Stephen J Klaus, et al.
Skeletal Muscle|May 31, 2016
The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regenerationRegan-Heng Zhang, Robert N Judson, David Y Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 31, 2010
Broadly absorbing black to transmissive switching electrochromic polymersPengjie Shi, Chad M Amb, Eric P Knott, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogueBabu J Mavunkel, Sarvajit Chakravarty, John J Perumattam, et al.
Gastroenterology|September 2, 2021
PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative ColitisWilliam J Sandborn, Larry C Mattheakis, Nishit B Modi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2020
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney DiseaseUghetta Del Balzo, Pierre E Signore, Gail Walkinshaw, et al.
Pageof 1